🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marino Venerito

John Radcliffe Hospital

ORCID: 0000-0001-8581-0974

Also affiliated with MRC Human Immunology Unit, University Hospital Magdeburg, Otto-von-Guericke-Universität Magdeburg

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma”.

Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma

Carcinogenesis(2020)10.1093/carcin/bgaa132

N/A

0DataRank · unranked

14 citations

Jianhong Chen, Li Yan, Qianchuan He, Puya Gharahkhani, Lynn Onstad +68 more

Sex-Specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma

Gastroenterology(2020)10.1053/j.gastro.2020.08.052

N/A

0DataRank · unranked

26 citations

Carlo Maj, Spiridon Tsavachidis, Quinn T. Ostrom, Puya Gharahkhani, Lesley A. Anderson +38 more

eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0096

N/A

0DataRank · unranked

8 citations

Puya Gharahkhani, David Levine, Rebecca C. Fitzgerald, Ines Gockel, Douglas A. Corley +65 more

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab

JHEP Reports(2024)10.1016/j.jhepr.2024.101295

N/A

0DataRank · unranked

9 citations

Philipp Mildenberger, Jennifer Gile, Fabian Jost‐Brinkmann, Bernhard Scheiner, Catherine Leyh +54 more